生物活性抑制剂是一类具有高生物活性的特殊小分子杂环化合物,这些小分子在生物体内通过氢键、疏水作用以及色散力等与特定的抗体及酶相互作用,使相应蛋白的二级结构和三级结构发生变化,从而起到一定的蛋白抑制活性。
麦克林试剂公司通过自主研发,以及和国内外药物化学专家合作,共同开发了近百种高效生物活性抑制剂。这些生物抑制剂作用的靶点应用广泛,包括P97、Hsp90、DRP1、HDAC6、K-Ras(G12C)、gelatinase、CB1、BET bromodomain、BET、COX-2、GSK-3等。
产品编号 | CAS号 | 项目名称规格 | 分子式 | 加入购物车 |
---|---|---|---|---|
N824559 | 177355-84-9 | DBeQ, 99% N,N'-Dibenzyl-2,4-quinazolinediamine, 99% |
C22H20N4 | |
D824560 | 252017-04-2 | 4-[[3-氯-4-[[(2R)-3,3,3-三氟-2-羟基-2-甲基-1-氧代丙基]氨基]苯基]磺酰基]-N,N-二甲基苯甲酰胺, 99% (2,4-Dihydroxy-5-isopropylphenyl)5-[(4-methyl-1-piperazinyl)meth yl]-1,3-dihydro-2H-isoindol-2-ylmethanone, 99% |
C19H18ClF3N2O5S | |
G824562 | 1086062-66-9 | 2,4-二氟-n-[2-甲氧基-5-[4-(4-吡嗪)-6-喹啉]-3-吡啶]苯磺酰胺, 99% GSK-2126458, 99% |
C25H17F2N5O3S | |
P815933 | 82508-31-4 | 土槿皮乙酸, 分析对照品 Pseudolaric acid B, 分析对照品 |
C23H28O8 | |
D824563 | 912999-49-6 | AT-13387, 99% (2,4-dihydroxy-5-propan-2-ylphenyl)-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydroisoindol-2-yl]methanone, 99% |
C24H31N3O3 | |
C824564 | 848695-25-0 | 6-氯-9-((4-甲氧基-3,5-二甲基吡啶-2-基)甲基)-9H-嘌呤-2-胺, 99% 6-Chloro-9-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-9H-purin-2-amine, 99% |
C14H15ClN6O | |
N824565 | 1206101-20-3 | N-(5-(4-((6-氰基吡啶-3-基)甲氧基)苯基)-[1,2,4]噻唑并[1,5-a]吡啶-2-基)环丙烷羧酰胺, 99% N-[5-[4-[(6-Cyano-3-pyridinyl)methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl] cyclopropanecarboxamide, 99% |
C23H18N6O2 | |
N824615 | 1197160-78-3 | N-[4-[[4-(二甲基氨基)-1-哌啶基]羰基]苯基]-N’-[4-[4,6-二(4-吗啉基)-1,3,5-三嗪-2-基]苯基]脲, 99% N-[4-[[4-(Dimethylamino)-1-piperidinyl]carbonyl]phenyl]-N'-[4-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)phenyl]-urea, 99% |
C32H41N9O4 | |
N824566 | 1029712-80-8 | 2-氟-N-甲基-4-[7-[(喹啉-6-基)甲基]咪唑并[1,2-B]-[1,2,4]三嗪-2-基]苯甲酰胺, 99% 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide, 99% |
C23H17FN6O | |
T824567 | 300801-52-9 | (Z)-1-(3-乙基-5-甲氧基-2,3-二羟基并噻唑-2-亚基)丙酮, 99% TG003, 99% |
C13H15NO2S | |
M824572 | 338967-87-6 | Mdivi-1, 99% Mdivi-1, 99% |
C15H10Cl2N2O2S | |
S824573 | 1009298-59-2 | 3-[2,4-双((3S)-3-甲基吗啉-4-基)吡啶并[5,6-E]嘧啶-7-基]-N-甲基苯甲酰胺, 99% 3-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-N-methylbenzamide, 99% |
C25H30N6O3 | |
T824574 | 1252003-15-8 | Tubastatin A, 99% Tubastatin A, 99% |
C20H21N3O2 | |
K824610 | K-Ras(G12C) inhibitor 6, 99% K-Ras(G12C) inhibitor 6, 99% |
C17H22Cl2N2O3S | ||
K824609 | 1469337-95-8 | K-Ras(G12C) inhibitor 12, 97% K-Ras(G12C) inhibitor 12, 97% |
C15H17ClIN3O3 | |
K824608 | 1469337-91-4 | K-Ras(G12C) inhibitor 9, 99% K-Ras(G12C) inhibitor 9, 99% |
C16H21ClIN3O4S | |
H824614 | 1469338-01-9 | 6H05, 99% 6H05, 99% |
C20H30ClN3O2S3.CF3COOH | |
R823899 | 877399-52-5 | 3-[(1R)-1-(2,6-二氯-3-氟苯基)乙氧基]-5-[1-(4-哌啶)-1H-吡唑-4-基]-2-吡啶胺, 98% 3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-Pyridinamine, 98% |
C21H22Cl2FN5O | |
P824605 | 292605-14-2 | SB-3CT, 99% 2-[(4-phenoxyphenyl)sulfonylmethyl]thiirane, 99% |
C15H14O3S2 | |
R824606 | 168273-06-1 | 利莫那班, 99% Rimonabant, 99% |
C22H21Cl3N4O |